SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology remains the center of intense market attention as traders aggressively buy the dip amid a surge of activity surrounding potential supply constraints in the memory sector and a high-profile executive business trip to China. Community sentiment is overwhelmingly bullish, with investors focusing on the stock's long-term growth potential in the AI cycle while dismissing short-term pullbacks as manufactured opportunities to accumulate shares.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors digest news that CEO Jensen Huang is joining President Trump's delegation to China, sparking intense community debate over potential chip sales and export restrictions. The stock is seeing significant institutional support ahead of upcoming earnings, with traders closely monitoring the potential impact of high-level trade negotiations on future revenue growth.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending after confirming its pivotal REGAL trial has reached 78 of 80 required events, signaling that final clinical trial data is imminent. The community is actively debating the potential for a significant short squeeze due to high short interest and discussing the long-term potential of the GPS treatment platform for AML patients.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology Group is seeing intense speculative volume and volatility, with the community actively debating whether the stock is undergoing a genuine short squeeze or an orchestrated pump-and-dump scheme. Investors are comparing its rapid price action to other low-float Chinese microcaps while debating the sustainability of these moves amid persistent concerns over dilution risks and regulatory factors.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is currently experiencing extreme momentum as traders aggressively chase a break above the 180 level, driven by intense speculation surrounding Nvidia's recent developments and China-related trade optimism. The community remains deeply divided, with bulls pointing to the ongoing AI infrastructure super-cycle as justification for the parabolic move, while a vocal group of bears warns of historic overbought levels and the severe volatility decay risks inherent in holding leveraged instruments during a potential market correction.

Tema ETF Trust - Tema Space Innovators ETF

The Tema Space Innovators ETF ($NASA) is trending due to its unique direct exposure to SpaceX via special purpose vehicles ahead of an anticipated mid-year IPO, sparking significant community interest as investors look for indirect ways to gain a stake in the private aerospace giant. Traders are actively debating whether this ETF will mirror the explosive performance of other niche funds by bundling popular space pure-plays like Rocket Lab, AST SpaceMobile, and Intuitive Machines into a single, accessible vehicle.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is trending as investors capitalize on its niche in radiation-hardened, high-reliability memory for aerospace, defense, and edge AI, with many drawing parallels to historical semiconductor market leaders. The stock is seeing high volatility and heavy retail interest, fueled by its low float and ongoing speculation about a potential gamma squeeze as the community monitors institutional accumulation and long-term sector tailwinds.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is capturing significant investor interest as the community weighs its robust $2.5 billion cash reserve against the risks of being a pre-revenue company. Bulls are focused on impending regulatory catalysts and data center partnerships, while skeptics remain wary of consistent insider selling and the long lead times for reactor deployment.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is surging as investors aggressively capitalize on a multi-year memory chip shortage driven by surging demand for AI infrastructure and HBM. The community remains overwhelmingly bullish, dismissing recent volatility as a buying opportunity while highlighting record-breaking asset inflows and the critical role of the fund's major holdings in the AI supply chain.

Memecoin on Injective taken over by the community.

Nonja

The community is rallying behind $NONJA as the premier meme token on the Injective blockchain, citing its robust liquidity, active governance, and perceived undervaluation as key catalysts for potential outperformance. Supporters are increasingly framing the token as a leveraged play on Injective's broader ecosystem recovery, emphasizing strong community retention despite long-term market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMRN 🔥 AMARIN&#39;S VAZKEPA® UK SALES POISED FOR EXPLOSIVE GROWTH! 🔥 
 
Big thanks to @CaptBeer for keeping us updated on UK English Prescribing Data (EPD)! 🫡 
 
Based on current trends, here’s the projected Vascepa (VAZKEPA®) sales in the UK for 2025: 
 
💊 Total Pills: 5.73M 
🍼 Total Bottles: 47.7K 
💰 Total Revenue: $7.37M 
 
📈 VAZKEPA® is steadily growing in the UK, with consistent monthly increases in prescriptions. 🚀 
 
This is a conservative baseline, but if uptake accelerates, we could see hockey stick-style growth as awareness spreads and guidelines shift. The groundwork is being laid for much faster scaling in the near future. 
 
The market is shifting, and momentum is building. Omacor’s days are numbered. ⏳

Suzanne Munoz

jblood83

Ron Veres

benn fine

Jeff

sanam

Long Only

sang jun

Scott

chisciana

Mike Everts

valerie

Mark Roth

Andrew Hero

Wikthor

bill leno

$AMRN Hello again my Friends: 
 
SLIDE 1/2 
 
The UK English Prescribing Data for January 2025 is in.  
 
Slide #1: Line chart and Table showing monthly (13 months from Jan 2024 to Jan 2025) Number of Capsules/Tablets for Bempedoic Acid, Bempedoic Acid + Ezetimibe, VAZKEPA®, OMG-3 EE (OMACOR). 
 
Slide #2: Market Shares and monthly changes between VAZKEPA® and OMACOR.  
 
It’s a slow grind in the UK. However, word is getting out and OMACOR is being slowly eroded by VAZKEPA®.

StockTwits Web

Amarin Corp - ADR

 🔥 AMARIN'S VAZKEPA® UK SALES POISED FOR EXPLOSIVE GROWTH! 🔥 
 
Big thanks to 

 for keeping us updated on UK English Prescribing Data (EPD)! 🫡 
 
Based on current trends, here’s the projected Vascepa (VAZKEPA®) sales in the UK for 2025: 
 
💊 Total Pills: 5.73M 
🍼 Total Bottles: 47.7K 
💰 Total Revenue: $7.37M 
 
📈 VAZKEPA® is steadily growing in the UK, with consistent monthly increases in prescriptions. 🚀 
 
This is a conservative baseline, but if uptake accelerates, we could see hockey stick-style growth as awareness spreads and guidelines shift. The groundwork is being laid for much faster scaling in the near future. 
 
The market is shifting, and momentum is building. Omacor’s days are numbered. ⏳

StockTwits for iOS

@SanDiegoLiving @CaptBeer IMO, $10M in 2025, from U.K. with other U.K. countries, my guess, E.U. starts to carry its weight in 2025.

Dan flint

 IMO, $10M in 2025, from U.K. with other U.K. countries, my guess, E.U. starts to carry its weight in 2025.

@SanDiegoLiving @CaptBeer hate to be a downer, but 7 million dollars is actually pretty pathetic.

Justin Hill

 hate to be a downer, but 7 million dollars is actually pretty pathetic.